chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started with a headache last night, and the left side of my face (sinuses) were inflamed and hurting. It continued through today.  This afternoon I developed a 101° fever,  chills, a slight cough, body aches, tiredness, and headache that doesn?t go away.
FEB92 aprox 24 hrs p/vax pt felt achy, h/a, w/genl malaise & some nausea; no tx did not relate to vax @ time since it was flu season; since all liver tests show elevated liver enzymes;
had fever/ individual had fever; This is a spontaneous report received from a contactable non-healthcare professional. A 43-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number and expiration date unknown) via an unspecified route of administration on 07Mar2021 at single dose (at 43-year-old) for COVID-19 immunization. The patient wasn't pregnant at the time of vaccination. The patient's medical history was not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination (none concomitant therapy). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number and expiration date unknown) at single dose on an unspecified date for COVID-19 immunization. The patient had fever/ individual had fever a day after the administration of the vaccine at 03:45 of 08Mar2021 (Monday) at 101-102 "degree c", reported as non-serious. The treatment [self administered paracetamol (TYLENOL)] was received for the event fever. Prior to/ since the vaccination, the patient wasn't diagnosed with COVID-19. The outcome of the event was resolved in Mar2021.  Information on the lot/batch number has been requested.
Minor headaches daily for months Redness at injection site lasting for months Duvet in arm where injected?are away at muscle?
skin rush all over their body; This spontaneous case was reported by a patient and describes the occurrence of SKIN REACTION (skin rush all over their body) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (skin rush all over their body). At the time of the report, SKIN REACTION (skin rush all over their body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
First 30 minutes after vaccination: Hot tingling sensation in forehead Cold tingling sensation on tip of tongue Slightly numb left leg Slightly upset stomach  First day after vaccination: Sore throat Fatigue Stiff arm
A report has been received from a medical representative on behalf of a nurse, concerning a patient of unknown age and gender. The patient's medical history, concurrent diseases and concomitant medications have not been reported. The patient received FLUMIST on an unknown date. This administration turned out to be inadvertent as the patient was on a list to get a kidney transplant. No adverse reaction has occurred. The outcome of inadvertent administration of FLUMIST to patient on kidney transplant waiting list was unknown. The report was considered to be non-serious by company physician. Corrected report on 14-Apr-2014: medical representative captured as reporter in addition: follow-up dates captured, as initial and follow-up were handled together; vaccine-related fields completed for first reporter and suspect product; narrative updated. The case has been updated with full data due to term additional for FLUMIST / Q/Laiv.
PENTACEL administered incorrectly. Green topped vial administered with plain sterile water diluent instead of DTaP-IPV component (blue top).
Tingling and numbness in shoulder, arm, hand, thumb, pointing finger, middle finger immediately after receiving vaccine that has not subsided. Unable to grasp objects without feeling numbness in hand, cannot lay on right side to fall asleep, numbness in shoulder.
2 Days after injection, red rash at injection site  from shoulder to elbow and spreader to inside of the arm.  Inflamed, swollen , red, burning and painful.     I had a Flu shot 2 weeks prior to shingles shot at the same pharmacy but can?t find the paperwork.  I did not have any side effects from the shot. It was in the right arm.
PATIENT RECEIVED FIRST COVID VACCINE AND STARTED FEELING DIZZY AT 15 MINUTE WINDOW, EMS WAS NOTIFIED AND HELPED CLIENT TO AMBULANCE. PATIENT WALKED TO AMBULANCE AND BACK TO HER VEHICLE WITHOUT ASSISTANCE. EMS FOUND PATIENT TO BE HAVING PANIC ATTACK, VITAL SIGNS STABLE, SLIGHT HEADACHE AFTER DIZZZINESS RESOLVED. PATIENT HAS HX OF R/A AND CARDIAC HISTORY AS WELL AS ANXIETY.
Reported numbness/tingling and muscle cramps in arms and fingers. Assessment performed. No wheezing/stridor, hives, angioedema. BPs ranged 133-120/68-80, HR 78-104 bpm. 911 called by employee while patient remained under observation. EMS arrived and assessed patient with similar vital signs. O2 therapy applied by EMS. Patient declined ER at this time and took rx xanax. Husband at her side. I came into patient area with EMS present and spoke to patient who appeared less worried/anxious. She removed O2. I asked if she wants further evaluation and she said yes and was transferred to local ER by EMS. Husband in car
I have always had a consistent monthly cycle or period. On are occasion, during extreme stress, I may start 2-3 days late, but nothing else changes. After my first dose of Moderna, I spotted 10+ days later for a day and then stopped. That period started at roughly the correct time, but was heavier than usual and was accompanied by intense night time cramping that kept me up. I did not make the connection at the time. Since then, I have continued to have trouble with my cycle; it will start days and even a week late, sometimes it starts early, I spot on a regular basis leading up to my period and it can be heavy spotting with no warning, the periods are shorter and heavier and my cramping has either been severe or minimal but lasting. The spotting and the inconsistent timing are not normal for me. i have had a full check up, been tested for all possible STD's, and tested for pregnancy: all tests were negative and my symptoms unexplainable. My doctor informed me that many woman had been making appointments in regards to altered menstrual cycles since receiving their Covid-19 vaccines.  These symptoms are not clearing up or lessening and  I'm concerned.  Please understand I do not regret receiving the vaccine, but many woman are having issues with their cycles and this needs to be heard, researched, and addressed. Especially with how much the vaccine is pushed and made mandatory. Why is this happening, how do we fix it, and get us some support, please.
Migraine with aura  resolved with OTC care. Unusual because patient does not have history of migraines.
had a calcium scan and found fluid around heart, additional bloodwork tests completed to see if there was a reason for this all other tests did not indicate any reason for fluid
pt recv vax 24APR98 & 30min p/vax pt devel macular papular rash on extremities, urticarial rash on trunk, h/a, nausea & diarrhea;
Liquid was running down the subject's arm while they were injecting the vaccine; A spontaneous report was received from a nurse concerning a 49-year-old, female patient who received Moderna's COVID-19 Vaccine, and liquid was running down the patient's arm while they were injecting the vaccine.   The patient's medical history was not provided. Concomitant medications were not provided.   The patient received their first of two planned doses of mRNA-1273 (Batch number 039K20A) on 07 Jan 2021 intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On an unknown date, liquid was running down the patient's arm while the vaccine was being injected.  The nurse was unsure why this had occurred.  Treatment information was not provided.   Action taken with the drug in response to the event was not applicable.   The outcome of the event was considered resolved.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273 (lot # 039K20A). There were no reported AEs associated with this case of incorrect dose administered.
Patient said he wanted a PREVNAR. So I gave him a PREVNAR. And when he got home and checked his records. He said he had that one last year and he was supposed to get a PNEUMOVAX. No adverse events have been experienced at this time.
extreme face pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (extreme face pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FACIAL PAIN (extreme face pain). At the time of the report, FACIAL PAIN (extreme face pain) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Arm  is sore; When raising elbow the shoulder have a big knot that is painful; big knot that is painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm  is sore), ARTHRALGIA (When raising elbow the shoulder have a big knot that is painful) and LYMPH NODE PAIN (big knot that is painful) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm  is sore), ARTHRALGIA (When raising elbow the shoulder have a big knot that is painful) and LYMPH NODE PAIN (big knot that is painful). At the time of the report, PAIN IN EXTREMITY (Arm  is sore), ARTHRALGIA (When raising elbow the shoulder have a big knot that is painful) and LYMPH NODE PAIN (big knot that is painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
COVID; COVID; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (Not Available). The reporter is the patient. Other Case identifier(s): 21K-163-4218801-00 (Agency).  A 51 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administration date 08Aug2021 (Batch/Lot number: unknown) at the age of 50 years as dose 2, single and intramuscular, administration date 17Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) at citrate free for psoriatic arthropathy. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID". The action taken for adalimumab was dosage permanently withdrawn. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No known allergies. Causality for HUMIRA (ADALIMUMAB): The reporter's causality for the event(s) of COVID was not provided. The reporter's assessment of the causal relationship of the events vaccination failure and COVID-19 with the suspect product was possible at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the events cannot be completely excluded.
16DEC97 on scheduled return visit to clinic pt mom reported a 10min episode of twitching involving head, eyes & arms 5th day p/prev visit;mom denies sz hx-no med attention was sought as of 16DEC97;28JAN98 pt neuro does not feel sz r/t vax
Fever (103 F) Chills Headache Light Sensitivity Muscle Aches  Vomiting
headaches; feeling "freezing cold; soreness on her left arm and a lot of pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches), FEELING COLD (feeling "freezing cold) and PAIN IN EXTREMITY (soreness on her left arm and a lot of pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017b21a and 043b21a) for COVID-19 vaccination.     Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX), SIMVASTATIN, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE (XIGDUO) for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 21-Apr-2021, the patient experienced HEADACHE (headaches), FEELING COLD (feeling "freezing cold) and PAIN IN EXTREMITY (soreness on her left arm and a lot of pain). At the time of the report, HEADACHE (headaches), FEELING COLD (feeling "freezing cold) and PAIN IN EXTREMITY (soreness on her left arm and a lot of pain) outcome was unknown. Not Provided          patient is using High blood pressure medication. patient is on medication Tylenol but that didn't helped   Reporter did not allow further contact
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 28-JUN-2016, the patient was vaccinated with an improperly  stored dose of PNEUMOVAX 23 "10PK-0.5 ml SD-PFS LLok wTip" (lot # M005286, expiration date: 08-OCT-2017, dose and route were unspecified). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 304 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 40 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Chills; Sweating; Headaches; Muscle aches; Pains; This is a spontaneous report from a contactable consumer (patient himself). A 51-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot# EL3247), via an unspecified route of administration on 16Feb2021 10:00 in right arm at single dose for covid-19 immunisation. The patient medical history was not reported.  Concomitant medication within 2 weeks of vaccination included venlafaxine hydrochloride (EFFEXOR XR), amlodipine besilate (NORVASC), atorvastatin (LIPITOR).  The patient previously took the first dose of bnt162b2 (PFIZER, lot# EL3247) on 27Jan2021 13:00 in right arm for covid-19 immunization. The patient previously took sulfur and experienced allergies: sulfur. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced chills, sweating, headaches, muscle aches and pains on 16Feb2021 16:00. No treatment was received for events. This case was reported as non-serious. Outcome of events were recovered in Feb2021.
he developed a possible allergic reaction; he had a rash following the injection; This spontaneous report was received from a medical assistant and refers to a 12-month-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with the first dose of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, administered for prophylaxis (strength, dose, dose number, lot number, expiration date, and route of administration were not provided), after three doses of  pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) (strength, formulation, dose description, lot number, expiration date, route of administration, and indication were not provided) to complete the scheme of four doses.  On an unknown date, the patient developed a possible allergic reaction (hypersensitivity), he had a rash following the injection, not at the injection site, but on other parts of his body. At the time of reporting, the outcome of the events was not provided.  The causal relationship between the events with the suspect therapies was not reported.
Pt vaccinated with PROHIBIT developed Epiglotittis. Blood Culture positive for H Influenza type B.
Headache, Myalgia, FATIGUE, HA, BODY ACHES Narrative: FATIGUE, HA, BODY ACHES after receiving  2nd COVID Pfizer vaccine causing loss of work.
rash on breast and tummy; I fainted; This case was reported by a consumer via interactive digital media and described the occurrence of fainting in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th November 2022, the patient received the 1st dose of Shingrix. On 26th November 2022, 1 days after receiving Shingrix, the patient experienced fainting (serious criteria GSK medically significant). On 27th November 2022, the patient experienced rash. On an unknown date, the outcome of the fainting and rash were unknown.   It was unknown if the reporter considered the fainting and rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 27 NOV 2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient reported that had first dose of Shingrix two days prior to the reporting. The patient fainted next morning. The patient was then detected rash on breast and tummy
Relentless vomiting 24 hours; Bloody stool; A spontaneous report was received from a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced relentless vomiting 24 hours and bloody stool.    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 19 Mar 2021, prior to the onset of the symptoms, the patient received their planned dose of mRNA-1273 (batch number not provided) for prophylaxis of COVID-19 infection.   On unknown date, the patient reported relentless vomiting for twenty-four hours and bloody stool. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, relentless vomiting 24 hours and bloody stool, were considered unknown.; Reporter's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested
Initial report received from healthcare professional on 23 Oct 2014. A female patient, whose age, medical history and concomitant medications were not reported, had received an intramuscular dose of FLUZONE (batch number: UI195AA, dose, dose number not reported) in left deltoid on 23 Oct 2014. It was reported that on 23 Oct 2014, the patient bled from injection site, stated she felt funny for a few minutes after the injection and had a strange taste in her mouth. Lab details and corrective treatments were not reported. The outcome of the event was reported as recovered. Documents held by sender: none.
Severe nauseau with onset around 3 hours after vaccine, followed by vomiting 5 hours after vaccination
Seven days after first dose, I developed migraine symptoms and shortly afterwards a "rash" bloomed around the vaccination site on my right arm. I took Advil for the headache, which diminished but didn't remove the pain/discomfort. But it lasted only 24 hours. The "rash" area became brighter and larger over 48 hours, and is now diminishing. The site was hot, itchy, tender. The arm's surface remained smooth.
The back of the roof of my mouth itched and swelled and I felt tightness in my chest. I had premeditated with Benadryl and Ranitidine which prevented an allergic reaction to the 2nd - 5th Vaccines.
Myalgia, NauseaVomiting, chills Narrative:  chills, body aches, and chills for 14 hours the next day after 1st injetion
Chills at 10pm, approximately 13 hours after the vaccine was received.  These lasted about an hour.  The following morning I woke up with significant fatigue, body aches, loss of appetite, hot and cold.  Slept off and on that day.  Went to bed at 7 pm and woke up 14 hours later, feeling back to normal.
Leg very sore; no throwing up; behavior nl; pt recvd APAP p/vax; no fever; looked like mosquito bites; 4MAY92 tc pt ok but bites still present; mom now thinks due to flea; Seen in ER; Given DPH;
We saw patient with a reaction to her pneumococcal vaccine. As you know, she is a very pleasant 25-year-old with allergic rhinitis and asthma whose respiratory allergic diseases have been pretty well controlled except frequent rhinorrhea. She was seen her on October 31st and given DYMISTA samples since the nasal steroid alone was inadequate. Her asthma was better controlled with DULCRA 200 2 puffs b.i.d. along with SINGULAIR. She needed her rescue inhaler much less often. At that visit, the pneumococcal vaccine was administered in the left deltoid since it is recommended that asthmatics be kept up to date on the PVAX. On November 1st, she noted a small red bump that morning. Later that day, she had a temperature of 102 that eventually spiked to 104 the next day. On November 2nd, she went to the urgent care with a large red knot and was given prednisone. The area is still exquisitely tender and red with a central purple area. She states it was bubbled up a couple of days ago but that fluid must have popped on the way over her. Overall, the affected area is decreasing except last night she noted some increase in redness at the inferior aspect of the reaction. She has not had any respiratory problems. Her fever has been gone since she was placed on prednisone. At urgent care, they told her she had a viral infection as the cause of her fever but had also given her prednisone presumably because of the large local reaction to the vaccine. On exam today, her left upper arm has an area of erythema of about 12 x 8 cm. Around the central area where the injection was administered, there is a 3 x 2 cm darker ecchymotic lesion. There is some appearance as if it had been a fluid-filled area though now drained. There is currently no drainage, fluctuants or purulence. The area is mildly warm and exquisitely tender.
Anaphylaxis to MMR vaccine). Injection given at approx 11:55-returned to office at 12:05 from parking lot. Returned with complaint of itching, hives to injection site, thighs. No respiratory distress, per pt felt "like a rock in throat". Diffuse erythema over face, chest, arms, palms/soles. Epi/Benadryl given. Observed and discharged to home at 2:05 PM.
Patient received the vaccine yesterday, had no issues until today. She reports symptoms of swelling, redness, and tenderness about 3 inches below the injection site.
Headache, Myalgia & Arthralgia Narrative: missed work following second dose due to symptoms
pt recvd vax; prolonged screaming x 6 days; no fever, no szs;